Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angioplasty, Balloon, Coronary | 6 | 2011 | 183 | 0.890 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2024 | 244 | 0.820 |
Why?
|
| Aortic Valve Stenosis | 2 | 2024 | 377 | 0.780 |
Why?
|
| Angina, Unstable | 3 | 2010 | 52 | 0.650 |
Why?
|
| Anticoagulants | 3 | 2010 | 607 | 0.580 |
Why?
|
| Fibrinolytic Agents | 2 | 2009 | 207 | 0.500 |
Why?
|
| Enoxaparin | 2 | 2009 | 44 | 0.490 |
Why?
|
| Myocardial Infarction | 5 | 2011 | 1061 | 0.460 |
Why?
|
| Hirudins | 1 | 2013 | 36 | 0.400 |
Why?
|
| Antithrombins | 1 | 2013 | 51 | 0.390 |
Why?
|
| Blood Coagulation | 1 | 2013 | 130 | 0.380 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 244 | 0.320 |
Why?
|
| Peptide Fragments | 1 | 2013 | 800 | 0.300 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2013 | 303 | 0.290 |
Why?
|
| Thrombosis | 2 | 2013 | 524 | 0.280 |
Why?
|
| Coronary Thrombosis | 1 | 2007 | 35 | 0.270 |
Why?
|
| Heparin | 1 | 2009 | 212 | 0.270 |
Why?
|
| Mammary Arteries | 1 | 2005 | 29 | 0.230 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2005 | 86 | 0.220 |
Why?
|
| Aortic Valve | 2 | 2024 | 482 | 0.210 |
Why?
|
| Blood Coagulation Tests | 1 | 2003 | 61 | 0.200 |
Why?
|
| Embolization, Therapeutic | 1 | 2005 | 223 | 0.190 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2023 | 157 | 0.170 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 328 | 0.160 |
Why?
|
| Risk Assessment | 3 | 2024 | 3731 | 0.150 |
Why?
|
| Coronary Disease | 1 | 2003 | 685 | 0.150 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2023 | 458 | 0.140 |
Why?
|
| Hemorrhage | 2 | 2013 | 519 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2009 | 289 | 0.120 |
Why?
|
| Risk Factors | 2 | 2024 | 10938 | 0.110 |
Why?
|
| Electrocardiography | 2 | 2011 | 995 | 0.110 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2013 | 13 | 0.100 |
Why?
|
| Stents | 3 | 2009 | 868 | 0.090 |
Why?
|
| Coronary Vasospasm | 1 | 2011 | 14 | 0.090 |
Why?
|
| Coronary Artery Disease | 2 | 2011 | 893 | 0.090 |
Why?
|
| Chest Pain | 1 | 2011 | 128 | 0.080 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2007 | 65 | 0.080 |
Why?
|
| Humans | 10 | 2024 | 132064 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1350 | 0.080 |
Why?
|
| Middle Aged | 5 | 2013 | 28993 | 0.070 |
Why?
|
| Injections, Subcutaneous | 1 | 2009 | 126 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 247 | 0.070 |
Why?
|
| Platelet Count | 1 | 2009 | 139 | 0.070 |
Why?
|
| Ticlopidine | 1 | 2007 | 29 | 0.070 |
Why?
|
| Troponin I | 1 | 2009 | 125 | 0.070 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2007 | 26 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2009 | 322 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2009 | 696 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2023 | 13000 | 0.060 |
Why?
|
| Aspirin | 1 | 2007 | 220 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2009 | 1255 | 0.060 |
Why?
|
| Peptides | 1 | 2009 | 846 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 1957 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 1177 | 0.050 |
Why?
|
| Logistic Models | 1 | 2009 | 1839 | 0.050 |
Why?
|
| Hematologic Agents | 1 | 2003 | 7 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 662 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 236 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 188 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2007 | 1300 | 0.050 |
Why?
|
| Male | 5 | 2013 | 64938 | 0.050 |
Why?
|
| Time Factors | 1 | 2013 | 6444 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2005 | 487 | 0.050 |
Why?
|
| Allografts | 1 | 2023 | 196 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 537 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2005 | 984 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2023 | 666 | 0.040 |
Why?
|
| Biomarkers | 1 | 2009 | 3403 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2003 | 663 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2023 | 540 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2013 | 17389 | 0.030 |
Why?
|
| Hypertension | 1 | 2005 | 1397 | 0.030 |
Why?
|
| Female | 4 | 2023 | 70664 | 0.030 |
Why?
|
| Adult | 3 | 2023 | 31571 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 1411 | 0.030 |
Why?
|
| Aged | 2 | 2011 | 21426 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 347 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2139 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 2311 | 0.010 |
Why?
|
| Economics, Pharmaceutical | 1 | 2003 | 6 | 0.010 |
Why?
|
| Factor Xa Inhibitors | 1 | 2003 | 66 | 0.010 |
Why?
|
| Child | 1 | 2023 | 25763 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 7107 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 1160 | 0.010 |
Why?
|